Diana Ernst, RPh

Gilead announced results from 2 Phase 3 studies for the investigational fixed-dose HIV regimen with bictegravir and emtricitabine for the treatment of treatment-naive adults with HIV.

A case study published by the CDC highlights the possible danger of maternal placenta capsule ingestion.

The FDA and CDC are warning consumers of a hepatitis A virus risk in contaminated frozen tuna.

A patient who recently acquired a new tattoo developed Vibrio vulnificus septic shock after swimming in seawater, leading to death.

ViiV Healthcare will discontinue Rescriptor Tablets for the treatment of HIV infection.

Report provides new recommendations and guidance for vaccination providers and travelers about the use of lyophilized CVD 103-HgR (Vaxchora, PaxVax, Redwood City, California).

The Drug Interactions section has been updated to include information on concomitant use of corticosteroids with 2 HIV medications.

Using certain antibiotics during early pregnancy increases the risk of spontaneous abortion.

The CDC has issued an alert regarding new recommendations for the treatment of Shigella infection.

Statin use was more common among older patients, men, those with CHD, hypertension, diabetes, and patients taking NRTIs and protease inhibitors.

Switching to TAF-based regimen was non-inferior to continuing TDF-based regimen in maintaining viral suppression.

First study to examine the benefit of treating GERD with proton pump inhibitors in reducing the acute respiratory infections complications.

Compared to infections by H1N1 or influenza B viruses, H3N2 influenza viruses have been associated with higher mortality in older adults.

Test uses procalcitonin as a biomarker to help make antibiotic management decisions in patients with lower respiratory tract infections and sepsis.

The US FDA is now allowing marketing of new automated test to identify organisms that cause bacermia and provide antibiotic sensitivity results.

Genvoya is indicated for adult and pediatric patients 12 years or older with HIV-1 infection who have no history of antiretroviral treatment.

Gilead Sciences has received approval to expand the indication for Truvada (emtricitabine/tenofovir disoproxil fumarate tablets) for pediatric patients with HIV-1.

The FDA has approved Fluad (influenza vaccine, adjuvanted; Seqirus) for the prevention of seasonal influenza in patients 65 years and older.

Caldolor is the first and only injectable non-steroidal anti-inflammatory drug (NSAID) approved for use in pediatric patients.

Hospitalized patients given acid-reducing drugs in the hospital have a higher risk of dying compared to those who do not receive the drugs.

Treatment of MRSA (methicillin-resistant Staphylococcus aureus) with certain antibiotics can potentially make patients sicker.

Low self-rated health is associated with worse immune system competence.

According to new research, there are four types of people who decide not to vaccinate due to issues of complacency, convenience, confidence, and calculation.

According to a National Institutes of Health (NIH) Study, infants exposed in the womb to the HIV drug tenofovir disoproxil fumarate, may have lower bone mineral content than those exposed to other anti-HIV drugs.

The FDA has issued a safety alert to consumers regarding the consumption of juice and cider that have not been pasteurized.

The Food and Drug Administration;s Vaccines and Related Biological Products Advisory Committee voted to recommend licensure of NVS Influenza Vaccines’ candidate vaccine.

The U.S. Food and Drug Administration finalized the first two of seven major rules under the bipartisan FDA Food Safety Modernization Act this week.

Canine influenza (or dog flu) is a contagious respiratory disease in dogs caused by specific Type A influenza viruses known to infect dogs, but to date there is no evidence of transmission to humans.